APLLTD2024-04-012024-06-30 APLLTD2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member APLLTD2024-06-30 APLLTD2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533573 APLLTD NOTLISTED Alembic Pharmaceuticals Limited Equity 2024-04-01 2025-03-31 2024-08-08 2024-07-25 INR Crores First quarter 11:00:00 13:15:00 2024-08-08 2024-08-08 Not applicable Single segment Pharmaceuticals 2024-04-01 2024-06-30 Unaudited Consolidated 15617280000.00 21040000.00 15638320000.00 4059310000.00 955000000.00 -1073390000.00 3797690000.00 131820000.00 690400000.00 5510410000.00 14071240000.00 1567080000.00 0.00 1567080000.00 388240000.00 -163340000.00 224900000.00 0.00 1342180000.00 0.00 0.00 0.00 3240000.00 1345420000.00 -33370000.00 1312050000.00 1347080000.00 -1660000.00 1313720000.00 -1670000.00 393130000.00 2 6.85 6.85 0.00 0.00 6.85 6.85 0.00 The excel file is not allowing us to mention details of Debt Service Coverage Ratio and Interest Service Coverage Ratio in two decimals. Hence, the details of the said Ratios for the quarter ended 30th June, 2024 are mentioned hereunder: Debt Service Coverage Ratio Quarter ended 30th June, 2024: 12.91 times Interest Service Coverage Ratio Quarter ended 30th June, 2024: 12.91 times Kindly take the note of the above. Others Expenses 5510410000.00 Items that will not be reclassified to profit / (loss) -39000000.00 -39000000.00 -6810000.00 1180000.00